From Fermentation to Vaccination: Non Animal Origin Squalene for High-Risk Applications
WEBINAR
In this webinar, you will:
- Understand the environmental consequences of extracting squalene from shark liver oil.
- Discover the advantages of fermentation-derived Non Animal Origin Squalene as a sustainable alternative.
- Assess the efficacy of fermentation-derived squalene in vaccine formulations compared to traditional sources.
Unlock the future of sustainable ingredients! Join us for an eye-opening webinar on fermentation-derived Non Animal Origin (NAO) Squalene. Discover how this innovative alternative addresses environmental concerns linked to shark liver oil and its pivotal role in vaccine adjuvant formulation.
Speakers
Priyanka Ram
Merck
Strategic Product Manager, Excipients Business
Priyanka Ram is a Global Strategic Product Manager in the Excipient Business, located in Burlington, MA, USA. She holds an M.S. in Biomedical Engineering and an M.S. in Innovation Management from Tufts University. Priyanka specializes in excipients for liquid formulation and downstream processing, with a particular focus on vaccine adjuvants.
Supriyadi Hafiz
Merck
Senior Scientist Formulation
Supriyadi Hafiz is a Senior Scientist Formulation and Technical Project Lead in Excipients R&D, based in Darmstadt, Germany. He holds an M.S. in Biosystem Technology from Darmstadt University of Applied Sciences, Germany. His research focuses on developing innovative solutions for vaccine adjuvant formulations, including alternative sustainable excipients, with the aim of enhancing efficacy and safety.
Pharma and biopharma manufacturing
- Downstream Processing
期间:1h
语言:English
场次 1:往期 February 26, 2026
如要继续阅读，请登录或创建帐户。
暂无帐户？